Search Result For: FDA
Date: 2025/04/10 - 19:00
HHS Cuts Programs That Help People Quit Smoking: What Are the Health Impacts?
The HHS has gutted key programs that help people quit smoking, including the CDC's Office on Smoking and Health. Experts say the federal cuts could increase smoking rates, related disease burden, and treatment costs.
Date: 2025/04/03 - 19:32
Supreme Court Appears Divided Over State-Level Cuts to Planned Parenthood Funding
The U.S. Supreme Court is deciding whether states can deny Medicaid funding to Planned Parenthood because the organization’s clinics perform abortions. The Trump administration has also temporarily frozen $27 million in Title X family planning funding designated for Planned Parenthood.
Date: 2025/04/02 - 23:32
Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/20 - 00:00
Compounding Pharmacies to Stop Making Ozempic, Zepound Knockoffs: What to Know
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.
Date: 2025/03/17 - 15:01
Mounjaro can boost weight loss in people without diabetes
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label treatment, according to a new study funded by pharmaceutical company Eli Lilly.
